Recent results of management of palpable clinically localized prostate cancer.

Outcomes of localized prostate cancer following conservative management. JAMA (2009) 5.57

Expectant management as an option for men with stage T1c prostate cancer: a preliminary study. World J Urol (1997) 0.87

An audit of the investigation and treatment of localised prostatic cancer in the south west region. Ann R Coll Surg Engl (1999) 0.80

Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects). Pathol Oncol Res (1996) 0.76

The prostate in Cleveland, Ohio. J R Soc Med (1998) 0.75

Measurement of prostate specific antigen as screening test for prostate cancer. Trials of treatment are needed before trials of screening. BMJ (1996) 0.75

Prostate cancer patients' refusal of cancer-directed surgery: a statewide analysis. Prostate Cancer (2015) 0.75

Recent results of management of palpable clinically localized prostate cancer. Cancer (1994) 0.75

Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden. Diabetologia (2009) 3.82

Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med (1979) 3.43

Epidemiology of cancer of the prostate. Cancer (1971) 2.19

Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies: identification of tissue-specific kidney glycoproteins. Proc Natl Acad Sci U S A (1981) 2.09

Deferred treatment of low grade stage T3 prostate cancer without distant metastases. J Urol (1993) 2.07

Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci U S A (1984) 2.02

Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med (1999) 1.94

Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: a population-based study. Lancet (1999) 1.89

The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement. Int J Radiat Oncol Biol Phys (1994) 1.73

Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma. J Urol (1993) 1.72

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. J Clin Oncol (1995) 1.71

Intermittent endocrine therapy for advanced prostate cancer. Cancer (1986) 1.60

Sarcomas of the kidney. J Urol (1984) 1.58

Epidemiology of adenocarcinoma of the kidney. J Natl Cancer Inst (1974) 1.58

The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. Int J Radiat Oncol Biol Phys (1991) 1.58

Experience with carcinoma of the scrotum. J Urol (1977) 1.57

The response of metastatic adenocarcinoma of the prostate to exogenous testosterone. J Urol (1981) 1.55

Cryptorchidism and testicular cancer. J Urol (1980) 1.52

Solitary metastasis from renal cell carcinoma. J Urol (1975) 1.52

Spermatic cord sarcoma in adults. J Urol (1978) 1.48

125I implantation for carcinoma of prostate. Further follow-up of first 100 cases. Urology (1982) 1.47

Review of an 8-year experience with modifications of endoscopic suspension of the bladder neck for female stress urinary incontinence. J Urol (1990) 1.43

Management of clinically localized prostatic cancer. An unresolved problem. JAMA (1993) 1.40

Testicular cancer in cryptorchids. Cancer (1982) 1.39

The natural course of prostatic carcinoma in relation to initial cytological grade. J Urol (1988) 1.38

Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res (1983) 1.38

Cystectomy + diversion for carcinoma of the bilharzial bladder. Prog Clin Biol Res (1988) 1.37

Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl (2000) 1.35

Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion. Br J Cancer (1992) 1.28

Autopsy findings in 154 patients with germ cell tumors of the testis. Cancer (1982) 1.27

Effect of cooking temperature on the formation of heterocyclic amines in fried meat products and pan residues. Carcinogenesis (1995) 1.25

Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. J Urol (1977) 1.24

The evolution of mature teratoma from malignant testicular tumors. Cancer (1977) 1.24

Dietary acrylamide and cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden. Br J Cancer (2003) 1.24

Toxicity of intravesical BCG and its management in patients with superficial bladder tumors. Cancer (1987) 1.23

Proceedings: Distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer (1974) 1.22

Natural history and staging of prostate cancer. Urol Clin North Am (1984) 1.21

Deferred treatment of clinically localized low-grade prostate cancer: actual 10-year and projected 15-year follow-up of the Karolinska series. Urology (1997) 1.20

Psychological complications after stillbirth--influence of memories and immediate management: population based study. BMJ (1996) 1.19

Waning sexual function--the most important disease-specific distress for patients with prostate cancer. Br J Cancer (1996) 1.18

Deferred treatment of clinically localized low grade prostate cancer: the experience from a prospective series at the Karolinska Hospital. J Urol (1994) 1.17

Penile cancer: relation of extent of nodal metastasis to survival. J Urol (1987) 1.16

Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model. Cancer (1977) 1.16

Cis-dichlorodiammineplatinum(II) in advanced bladder cancer. Cancer Treat Rep (1976) 1.15

Immunoanatomic dissection of the human urinary tract by monoclonal antibodies. J Histochem Cytochem (1984) 1.15

Meat, cooking methods and colorectal cancer: a case-referent study in Stockholm. Int J Cancer (1991) 1.14

Hormone-refractory (D3) prostate cancer: refining the concept. Urology (1995) 1.14

Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer. Proc Natl Acad Sci U S A (1985) 1.14

Proceedings: The natural history of prostatic cancer. Cancer (1973) 1.14

Regional lymph node metastasis from bladder cancer. J Urol (1981) 1.14

Complications of 125iodine implantation and pelvic lymphadenectomy in the treatment of prostatic cancer. J Urol (1979) 1.13

Lymphocyte stimulation: selective destruction of cells during blastogenic response to transplantation antigens. Science (1971) 1.13

Endoscopic diagnosis and treatment of upper-tract urothelial tumors. A preliminary report. Cancer (1985) 1.13

Malignant tumors of the spermatic cord. Cancer (1969) 1.13

Similarities and differences in assessing nausea on a verbal category scale and a visual analogue scale. Cancer Nurs (1997) 1.12

Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea--a randomized controlled study. Ann Oncol (2011) 1.11

Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer. J Clin Oncol (1988) 1.11

The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer (1987) 1.10

Selected experience with surgery and combination chemotherapy in the treatment of nonseminomatous testis tumors. J Urol (1983) 1.09

Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma. Cancer Genet Cytogenet (1987) 1.09

Expectant management of clinically localized prostatic cancer. J Urol (1994) 1.09

Primary carcinoma of the ureter: a prognostic study. Cancer (1975) 1.08

Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function? Eur J Cancer (2003) 1.08

Implantation of 125I in prostatic cancer. Surg Clin North Am (1974) 1.08

Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls. Int J Gynecol Cancer (2006) 1.07

Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life. Int J Radiat Oncol Biol Phys (1995) 1.07

Phase II trial of sequentially administered cisplatin, cyclophosphamide and doxorubicin for urothelial tract tumors. J Urol (1983) 1.06

Intake of fried meat and risk of cancer: a follow-up study in Finland. Int J Cancer (1994) 1.05

Sequential bilateral germ cell tumors of the testis despite interval chemotherapy. J Urol (1979) 1.05

Diet, body mass and colorectal cancer: a case-referent study in Stockholm. Int J Cancer (1990) 1.05

Behavioral patterns of prostate adenocarcinoma following an 125I implant and pelvic node dissection. Int J Radiat Oncol Biol Phys (1977) 1.04

Delayed chemotherapy-induced nausea is augmented by high levels of endogenous noradrenaline. Br J Cancer (1994) 1.04

Adriamycin in advanced urinary tract cancer: experience in 42 patients and review of the literature. Cancer (1977) 1.03

A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer. J Clin Oncol (1987) 1.03

Aspects of misclassification of confounding factors. Am J Ind Med (1992) 1.03

Combined chemotherapy and surgery in treatment of advanced germ-cell tumors. Cancer (1981) 1.03

Effect of intravesical Bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder. Cancer (1983) 1.02

The unrecognised cost of cancer patients' unrelieved symptoms:a nationwide follow-up of their surviving partners. Br J Cancer (2002) 1.02

VAB-6 combination chemotherapy in disseminated cancer of the testis. Ann Intern Med (1981) 1.01

Intratesticular germ cell tumors: observations on the effect of chemotherapy. J Urol (1981) 1.00

Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression. J Urol (1989) 1.00

Deferred treatment in clinically localised prostatic carcinoma. Br J Urol (1992) 1.00

Endogenous cortisol exerts antiemetic effect similar to that of exogenous corticosteroids. Br J Cancer (1993) 0.99

Human and mouse embryonal carcinoma cells in culture share an embryonic antigen (F9). Nature (1977) 0.99

Primary mediastinal germ cell tumors. Cancer (1974) 0.99

Surgical treatment of adult germinal testis tumors. Semin Oncol (1979) 0.98

Feelings of loss and uneasiness or shame after removal of a testicle by orchidectomy: a population-based long-term follow-up of testicular cancer survivors. Int J Androl (2011) 0.98

Seminal fluid and spermatozoon zinc levels and their relationship to human spermatozoon motility. Fertil Steril (1971) 0.97

Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis. J Clin Oncol (1984) 0.97

Adriamycin and cyclophosphamide in advanced bladder cancer. Cancer Treat Rep (1977) 0.97

VAB-4 combination chemotherapy in the treatment of metastatic testis tumors. Cancer (1981) 0.96

Ureteral carcinoma in situ after successful intravesical therapy for superficial bladder tumors: incidence, possible pathogenesis and management. J Urol (1987) 0.95

p53 mutations in urinary bladder cancer. Br J Cancer (2001) 0.95

An overview of intravesical therapy for superficial bladder tumors. J Urol (1987) 0.95

Renal pelvic tumors. JAMA (1971) 0.95

Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases. J Urol (1977) 0.94

Emotional isolation: prevalence and the effect on well-being among 50-80-year-old prostate cancer patients. Scand J Urol Nephrol (2001) 0.94

The role of neoadjuvant hormonal manipulation in localized prostatic cancer. Cancer (1993) 0.93

Multiple myeloma in Swedish agricultural workers. Int J Epidemiol (1986) 0.93

The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer. Cancer (1981) 0.93